In this Section
3368.0 Healthy Fluoridated Communities
Monday, October 31, 2011: 2:30 PM
This session will provide up-to-date information on 1. The HHS recommendation to fluoridate community water supplies at 0.7 mg/L for all US communities, replacing the previous recommendation, since 1962, of a range from 0.7 to 1.2 mg/L according to average ambient air temperature. HHS cited two reasons for the change: increased sedentary lifestyle with reduced regional variability in water consumption; and increase in the prevalence and severity of dental fluorosis. 2. In January 2011, EPA announced plans to review the current national primary drinking water standard for fluoride, which establishes a maximum contaminant level (MCL) and maximum contaminant level goal (MCLG) for naturally occurring fluoride in drinking water of 4.0 mg/L to protect against crippling skeletal fluorosis. EPA is acting on a 2006 report from the National Research Council (NRC) recommending that severe dental fluorosis is not just a cosmetic effect of excessive fluoride intake during tooth development as previous reports had indicated, but is an adverse health effect due to increasing the risk for dental caries as a result of pitting of enamel in severe dental fluorosis. Following a recommendation from the NRC, the U.S. EPA conducted a dose-response assessment for severe dental fluorosis and updated the exposure assessment for fluoride from that supporting the 1986 MCLG/MCL of 4.0 mg/L. EPA released the dose response and exposure assessments in January 2011 when EPA announced its plans to review the drinking water standard.
Session Objectives: Attendees will be able to 1. Describe the rationale for supporting community water fluoridation 2. Identify key factors in recommending a standard 0.7 ppm fluoride concentration in drinking water for the U.S.A. 3. Identify key factors that EPA has to consider when evaluating whether it is appropriate to revise the MCLG/MCL for fluoride in drinking water for the U.S.A. 4. Describe the difference between fluoridation level and MCL. 5. Identify key messages to the public and stakeholders on this topic.
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by: Oral Health
See more of: Oral Health